52 North Health Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

52 North Health Ltd - overview

Established

2018

Location

Cambridge, -, UK

Primary Industry

Medical Devices & Equipment

About

Founded in 2018 and based in Cambridge, UK, 52 North Health Ltd operates as a medical technology that provides medical equipment for cancer patients. In April 2022, led by new investor Cambridge Enterprise, other new investors Crista Galli Ventures, King's Health Partners, Parkwalk Advisors, Meltwind, Milltrust International, with participation from individual investors, raised 1 GBP million for 52 North Health Ltd. The firm offers a fully integrated AI and medical base device, neutrocheck that aims to improve the health outcome of the patient receiving chemotherapy by finger-prick blood test providing both white blood cell count and lactate level. The neutrocheck identifies the patients with the risk of life-threatening infections known as neutropenic sepsis.


The April 2022 funding will be used to take the NeutroCheck device through clinical trials in the U. K. and deliver on strategic partnerships with key partners.


Current Investors

Cambridge Enterprise, Parkwalk Advisors, Milltrust International

Primary Industry

Medical Devices & Equipment

Sub Industries

Oncology/Cancer Treatment, Monitoring Equipment

Website

www.52north.health

Verticals

Artificial Intelligence, Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

52 North Health Ltd - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.